FindTrial
Sign In

Atrophic Rhinitis new treatment

Effect of NasoBiome on Nasal microbiome profile of patients suffering from Atrophic Rhinitis- A Randomized control trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040478
Enrollment
30
Registered
2022-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J398- Other specified diseases of upperrespiratory tract

Interventions

Intervention1: Cases with Nasobiome nasal spray: Duration of intervention 3 months Total duration of study 3 years Controls would get Normal Saline nasal spray Followed up after the period of interven

Sponsors

Department of Science and Technology Government of Odisha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults (more than 18 years); Atrophic Rhinitis based on clinical examination2.

Exclusion criteria

Exclusion criteria: Pregnancy, comorbidities that preclude travel for follow up, declining to be included in the study, a SNOT22 score of less than 10.

Design outcomes

Primary

MeasureTime frame
To assess the improvement in clinical features following intervention using endoscopy score. To assess the change in nasal microbiome following interventionTimepoint: 3 years—

Secondary

MeasureTime frame
To assess the improvement in clinical features following intervention using endoscopy score. To assess the change in nasal microbiome following interventionTimepoint: 3 Years—

Countries

India

Contacts

Public ContactSAURAV SARKAR

All India Institute of Medical Sciences, Bhubaneswar

doc.sauravsarkar@gmail.com09830315933

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026